Cellebrite DI (CLBT) - Total Liabilities
Based on the latest financial reports, Cellebrite DI (CLBT) has total liabilities worth $454.53 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cellebrite DI - Total Liabilities Trend (2019–2025)
This chart illustrates how Cellebrite DI's total liabilities have evolved over time, based on quarterly financial data. See CLBT working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Cellebrite DI Competitors by Total Liabilities
The table below lists competitors of Cellebrite DI ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Growthpoint Properties Ltd
JSE:GRT
|
South Africa | ZAC69.92 Billion |
|
Dana Inc
NYSE:DAN
|
USA | $6.89 Billion |
|
Hyundai Steel
KO:004020
|
Korea | ₩14.60 Trillion |
|
Jiangsu Changshu Rural Commercial Bank Co Ltd
SHG:601128
|
China | CN¥369.64 Billion |
|
Jilin Power Share Co Ltd
SHE:000875
|
China | CN¥60.72 Billion |
|
Qingdao Gon Technology Co Ltd
SHE:002768
|
China | CN¥12.38 Billion |
|
Shufersal
TA:SAE
|
Israel | ILA11.23 Billion |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521
|
China | CN¥12.36 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Cellebrite DI's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CLBT company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.94 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cellebrite DI's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cellebrite DI (2019–2025)
The table below shows the annual total liabilities of Cellebrite DI from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $454.53 Million | +28.20% |
| 2024-12-31 | $354.55 Million | -28.90% |
| 2023-12-31 | $498.67 Million | +51.38% |
| 2022-12-31 | $329.43 Million | -20.26% |
| 2021-12-31 | $413.13 Million | +37.44% |
| 2020-12-31 | $300.58 Million | +35.76% |
| 2019-12-31 | $221.41 Million | -- |
About Cellebrite DI
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exp… Read more